Scarica l'app Stockscreener
22.87
0.40%
0.09
Dopo l'orario di chiusura:
22.87
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$22.78
Aprire:
$22.95
Volume 24 ore:
1.14M
Relative Volume:
0.94
Capitalizzazione di mercato:
$1.52B
Reddito:
$5.79M
Utile/perdita netta:
$-199.61M
Rapporto P/E:
-7.598
EPS:
-3.01
Flusso di cassa netto:
$-188.48M
1 W Prestazione:
+3.58%
1M Prestazione:
+3.34%
6M Prestazione:
+8.39%
1 anno Prestazione:
-47.39%
Intervallo 1D:
$22.59
$23.48
Intervallo di 1 settimana:
$21.77
$23.69
Portata 52W:
$14.40
$47.00
Celldex Therapeutics Inc Stock (CLDX) Company Profile
Nome
Celldex Therapeutics Inc
Settore
Industria
Telefono
908-200-7500
Indirizzo
53 FRONTAGE ROAD, HAMPTON
Confronta CLDX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CLDX
Celldex Therapeutics Inc
|
22.87 | 1.51B | 5.79M | -199.61M | -188.48M | -3.01 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Celldex Therapeutics Inc Stock (CLDX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-04-28 | Iniziato | Canaccord Genuity | Buy |
| 2025-03-20 | Iniziato | Morgan Stanley | Overweight |
| 2025-02-13 | Iniziato | UBS | Buy |
| 2024-10-07 | Iniziato | Citigroup | Buy |
| 2024-09-30 | Iniziato | Goldman | Neutral |
| 2024-09-27 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2024-06-18 | Iniziato | Stifel | Buy |
| 2024-06-11 | Iniziato | Wolfe Research | Outperform |
| 2023-12-20 | Iniziato | TD Cowen | Outperform |
| 2023-11-10 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2023-08-22 | Iniziato | Wells Fargo | Underweight |
| 2021-09-17 | Iniziato | Jefferies | Buy |
| 2021-09-10 | Iniziato | SVB Leerink | Outperform |
| 2021-07-22 | Iniziato | Guggenheim | Buy |
| 2020-02-21 | Iniziato | Cantor Fitzgerald | Overweight |
| 2017-08-01 | Ripresa | H.C. Wainwright | Buy |
| 2016-11-07 | Iniziato | Aegis Capital | Buy |
| 2016-03-08 | Downgrade | Jefferies | Buy → Hold |
| 2016-03-07 | Downgrade | Guggenheim | Buy → Neutral |
| 2016-03-07 | Downgrade | Leerink Partners | Outperform → Mkt Perform |
| 2016-03-07 | Downgrade | Wedbush | Outperform → Neutral |
| 2016-03-01 | Iniziato | H.C. Wainwright | Buy |
| 2015-08-11 | Reiterato | Brean Capital | Buy |
| 2015-08-11 | Reiterato | Oppenheimer | Outperform |
| 2015-08-11 | Reiterato | ROTH Capital | Buy |
| 2015-06-02 | Reiterato | WBB Securities | Strong Buy |
| 2014-11-17 | Reiterato | ROTH Capital | Buy |
| 2014-03-04 | Reiterato | Oppenheimer | Outperform |
| 2013-07-08 | Reiterato | Cantor Fitzgerald | Buy |
| 2013-03-08 | Reiterato | Cantor Fitzgerald | Buy |
| 2013-02-26 | Reiterato | Oppenheimer | Outperform |
| 2013-01-10 | Reiterato | Cantor Fitzgerald | Buy |
| 2012-10-02 | Reiterato | Oppenheimer | Outperform |
| 2012-09-14 | Reiterato | Cantor Fitzgerald | Buy |
Mostra tutto
Celldex Therapeutics Inc Borsa (CLDX) Ultime notizie
What machine learning models say about Celldex Therapeutics Inc.Market Activity Report & AI Forecast for Swing Trade Picks - Newser
Using economic indicators to assess Celldex Therapeutics Inc. potentialAnalyst Upgrade & Low Drawdown Trading Strategies - Newser
How to read the order book for Celldex Therapeutics Inc.Market Growth Report & Community Verified Trade Alerts - Newser
Chart based exit strategy for Celldex Therapeutics Inc.July 2025 Trade Ideas & Daily Chart Pattern Signal Reports - Newser
Can Celldex Therapeutics Inc. maintain sales growthTrade Ideas & Consistent Return Investment Signals - خودرو بانک
Can Sage Therapeutics Inc. sustain its profitabilityQuarterly Profit Review & Growth Focused Entry Point Reports - خودرو بانک
Is a relief rally coming for Celldex Therapeutics Inc. holdersDip Buying & Low Drawdown Trading Techniques - Newser
Is Celldex Therapeutics Inc. stock entering bullish territoryJuly 2025 Trends & Safe Investment Capital Preservation Plans - Newser
Published on: 2025-09-05 14:01:34 - Newser
How to manage a losing position in Celldex Therapeutics Inc.Weekly Profit Report & Long-Term Safe Return Strategies - Newser
Live market analysis of Celldex Therapeutics Inc.2025 Retail Activity & Stepwise Trade Execution Plans - Newser
Published on: 2025-09-05 06:06:23 - Newser
Will a bounce in Celldex Therapeutics Inc. offer an exitBond Market & Fast Entry and Exit Trade Plans - Newser
How to build a custom watchlist for Celldex Therapeutics Inc.Earnings Trend Report & Daily Technical Stock Forecast Reports - Newser
Analyzing drawdowns of Celldex Therapeutics Inc. with statistical toolsTrade Exit Report & Community Consensus Picks - Newser
Can you recover from losses in Celldex Therapeutics Inc.Portfolio Risk Report & Safe Swing Trade Setup Alerts - Newser
Technical analysis overview for Celldex Therapeutics Inc. stockRecession Risk & Safe Capital Investment Plans - Newser
Can Celldex Therapeutics Inc. outperform in the next rallyForecast Cut & High Yield Stock Recommendations - خودرو بانک
What technical models suggest about Celldex Therapeutics Inc.’s comebackPortfolio Performance Report & Fast Entry High Yield Tips - Newser
What indicators show strength in Celldex Therapeutics Inc.Market Activity Report & Daily Profit Maximizing Trade Tips - Newser
How Celldex Therapeutics Inc. stock performs during market volatility2025 Historical Comparison & Stepwise Trade Signal Implementation - Newser
Is Celldex Therapeutics Inc. trending in predictive chart modelsShare Buyback & Community Consensus Trade Alerts - Newser
Backtesting results for Celldex Therapeutics Inc. trading strategiesMarket Activity Report & Advanced Swing Trade Entry Plans - Newser
Does Celldex Therapeutics Inc. have high return on assetsTrade Entry Report & AI Powered Market Entry Ideas - خودرو بانک
Analyzing recovery setups for Celldex Therapeutics Inc. investorsWeekly Trading Summary & Weekly High Potential Stock Alerts - Newser
Is Celldex Therapeutics Inc. stock poised for growthWeekly Stock Summary & Short-Term Trading Opportunity Alerts - Newser
Target diversity creates opportunity in chronic urticaria - biocentury.com
Custom strategy builders for tracking Celldex Therapeutics Inc.July 2025 Opening Moves & Reliable Price Action Trade Plans - Newser
Is Celldex Therapeutics Inc. gaining market shareJuly 2025 Fed Impact & AI Enhanced Trading Signals - خودرو بانک
will a bounce in celldex therapeutics inc. offer an exitJuly 2025 Pullbacks & Weekly Chart Analysis and Guides - Newser
Should I set a stop loss on Celldex Therapeutics Inc.Volume Spike & Verified Entry Point Signals - خودرو بانک
Is Celldex Therapeutics Inc. impacted by rising ratesMarket Sentiment Report & Comprehensive Market Scan Reports - khodrobank.com
Historical volatility pattern of Celldex Therapeutics Inc. visualizedAnalyst Upgrade & Community Supported Trade Ideas - Newser
Is Celldex Therapeutics Inc. on track to beat earningsQuarterly Performance Summary & Entry and Exit Point Strategies - خودرو بانک
Published on: 2025-09-03 03:10:59 - خودرو بانک
Celldex Therapeutics Inc. Recovery Gathers Momentum on Chart SignalsQuarterly Market Review & Verified Momentum Stock Alerts - beatles.ru
Celldex Therapeutics Inc Azioni (CLDX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.40%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):